Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Therapeutic potential of the neutralizing monoclonal antibody 45G3 against encephalomyocarditis virus

Abstract Encephalomyocarditis virus (EMCV), a potential zoonotic pathogen, poses significant socioeconomic and public health challenges across various host species. Although EMCV rarely triggers severe clinical symptoms in humans, its widespread prevalence and unique biological characteristics under...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yanfang Zhang, Zhiying Wang, Yaohui Fang, Qiong Zhu, Jie Fu, Sijing Hu, Jiayin Jin, Min Zhou, Xijia Liu, Danna Zhang, Shouwei Huang, Yali Deng, Lingling Xie, Shu Shen, Jing Ye, Fei Deng, Shengbo Cao
Format:	Article
Language:	English
Published:	BMC 2025-01-01
Series:	Animal Diseases
Subjects:	Encephalomyocarditis virus Monoclonal antibody Virus-like particles Neutralizing activity Therapeutic efficacy Antiviral development
Online Access:	https://doi.org/10.1186/s44149-024-00154-7
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Preparation and application of porcine broadly neutralizing monoclonal antibodies in an immunoassay for efficiently detecting neutralizing antibodies against foot-and-mouth disease virus serotype O
by: Yimei Cao, et al.
Published: (2025-02-01)

Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2024-10-01)

Corrigendum: Editorial: Antiviral monoclonal antibody therapies
by: Catalina Florez, et al.
Published: (2025-02-01)

A Comprehensive Review of the Development and Therapeutic Use of Antivirals in Flavivirus Infection
by: Aarti Tripathi, et al.
Published: (2025-01-01)

Preparation and application evaluation of monoclonal antibodies against Monkeypox virus A29 protein
by: Ai Xiangjun, et al.
Published: (2025-01-01)

Development of a water-dispersible antimicrobial lipid mixture to inhibit African swine fever virus and other enveloped viruses
by: Joshua A. Jackman, et al.
Published: (2025-01-01)

Development and evaluation of a recombinant monoclonal human antibody with virus-neutralizing activity against the F glycoprotein of respiratory syncytial virus
by: Sergey A. Klotchenko, et al.
Published: (2024-12-01)

TRIM8 inhibits porcine epidemic diarrhoea virus replication by targeting and ubiquitinately degrading the nucleocapsid protein
by: Zhenbin Bi, et al.
Published: (2025-01-01)

Potentials of antiviral therapy at patients with liver cirrhosis in an outcome of HCV-infection
by: E. N. Bessonova
Published: (2011-06-01)

Anti-HSV-1 agents: an update
by: Wenwen Lv, et al.
Published: (2025-01-01)

Formulation and optimization of polymeric nanoparticles loaded with riolozatrione: a promising nanoformulation with potential antiherpetic activity
by: Solís-Cruz Guadalupe Y., et al.
Published: (2023-09-01)

Characteristics of the monkeypox virus isolate obtained from the first patient in Russia and its sensitivity to 7-[N-(4-trifluoromethylbenzoyl)-hydrazinocarbonyl]-tricyclo-[3.2.2.0^2,4]non-8-en-6-carboxylic acid
by: Alena S. Ovchinnikova, et al.
Published: (2024-12-01)

Characterization of two neutralizing monoclonal antibodies with conformational epitopes against porcine deltacoronavirus
by: Wan Lu, et al.
Published: (2025-01-01)

Cost-savings and health impact of strategies for prevention of Respiratory Syncytial Virus with nirsevimab in Chile based on the integrated analysis of 2019–2023 national databases: A retrospective study
by: Denis Sauré, et al.
Published: (2025-04-01)

Flunarizine as a Candidate for Drug Repurposing Against Human Pathogenic Mammarenaviruses
by: Chukwudi A. Ofodile, et al.
Published: (2025-01-01)

Antiviral activity of Ferula assa-feotida on HSV-1, 2 in vitro
by: Javad Charostad, et al.
Published: (2024-12-01)

Advances and Challenges in Antiviral Development for Respiratory Viruses
by: Luis Adrián De Jesús-González, et al.
Published: (2024-12-01)

Decitabine Increases the Transcription of <i>RIG-I</i> Gene to Suppress the Replication of Feline Calicivirus and Canine Influenza Virus
by: Shaotang Ye, et al.
Published: (2025-01-01)

Boosting the human antiviral response in conjunction with natural plant products
by: Rashmi Srivastava, et al.
Published: (2025-01-01)

How to use monoclonal antibody-based therapy in ALL
by: Erica Brivio, et al.
Published: (2025-06-01)

Accelerating the momentum to achieve global elimination of hepatitis B infection: a scoping review of hepatitis B guidelines to reduce mother to child transmission
by: Ka Wang Cheung, et al.
Published: (2025-02-01)

Regulation of viral replication by host restriction factors
by: Ying Lin, et al.
Published: (2025-01-01)

Single monoclonal spike characterized as double monoclonal gammopathy in a patient with multiple myeloma: A rare finding
by: Rajni Saijpaul, et al.
Published: (2023-01-01)

The Strategies Used by Animal Viruses to Antagonize Host Antiviral Innate Immunity: New Clues for Developing Live Attenuated Vaccines (LAVs)
by: Na Chen, et al.
Published: (2025-01-01)

HDAC6 Facilitates PRV and VSV Infection by Inhibiting Type I Interferon Production
by: Hu Zheng, et al.
Published: (2025-01-01)

Exploiting venom toxins in paratransgenesis to prevent mosquito-borne disease
by: Stephanie French, et al.
Published: (2025-01-01)

IS IT POSSIBLE TO PREDICT TUMOR PROGRESSION THROUGH GENOMIC CHARACTERIZATION OF MONOCLONAL GAMMOPATHY AND SMOLDERING MULTIPLE MYELOMA?
by: Ugo Testa, et al.
Published: (2024-04-01)

Spatiotemporal regulation of alginate sub-structures at multiple scales revealed by monoclonal antibodies
by: Catherine T. Jones, et al.
Published: (2025-06-01)

Selective suppression of influenza A/H5N1 virus replication <i>in vitro</i> using nanocomplexes consisting of siRNA and aminopropylsilanol nanoparticles
by: Marina N. Repkova, et al.
Published: (2024-12-01)

HDAC1 and HDAC2 Are Involved in Influenza A Virus-Induced Nuclear Translocation of Ectopically Expressed STAT3-GFP
by: Jessica Leong, et al.
Published: (2024-12-01)

Association of hepatitis B virus DNA levels with efficacy and safety and the impact of antiviral therapy on prognosis in liver cancer patients receiving immune checkpoint inhibitors therapy: a systematic review and meta-analysis
by: Hongxia Cui, et al.
Published: (2025-01-01)

The safety, pharmacokinetics and neutralizing activity of recombinant human anti-rabies monoclonal antibody NM57 injection (rhRIG, Ormutivimab) in combination with rabies vaccination in Chinese healthy adults: A phase Ib randomized, double-blind, parallel-controlled clinical study
by: Yin Yin, et al.
Published: (2025-01-01)

Learn from international recommendations and experiences of countries that have successfully implemented monoclonal antibody prophylaxis for prevention of RSV infection
by: Sara Manti, et al.
Published: (2025-02-01)

Concurrent presentation of proliferative glomerulonephritis with monoclonal immunoglobulin deposits and light chain proximal tubulopathy: a case report and review of the literature
by: Jingdong Zhang, et al.
Published: (2025-01-01)

Development of monoclonal antibodies against P. gingivalis Mfa1 and their protective capacity in an experimental periodontitis model
by: Mingya Cao, et al.
Published: (2025-01-01)

Development of an Enzyme-Linked Immunosorbent Assay Based on a Monoclonal Antibody for the Rapid Detection of Citrinin in Wine
by: Xingdong Yang, et al.
Published: (2024-12-01)

Animal Models, Therapeutics, and Vaccine Approaches to Emerging and Re-Emerging Flaviviruses
by: Thomas J. Baric, et al.
Published: (2024-12-01)

Concentration of viruses and electron microscopy
by: I. D. Petrova, et al.
Published: (2020-05-01)

Current Views of Torque Teno Virus (TTV) in Liver Diseases
by: I. V. Maev, et al.
Published: (2020-09-01)

Advances in antiviral strategies targeting mosquito-borne viruses: cellular, viral, and immune-related approaches
by: Ayyaz Khan, et al.
Published: (2025-02-01)